Global Consortium for Depression Prevention York 10 th December 2019 Prof Pim Cuijpers Overview Why is prevention important Is prevention effective How to increase the impact of prevention on incident cases ID: 916039
Download Presentation The PPT/PDF document "Can we prevent depression? The story so ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Can we prevent depression? The story so far from 30 years of research
Global Consortium for Depression Prevention
York, 10
th
December 2019
Prof. Pim
Cuijpers
Slide2Overview
Why is prevention important?Is prevention effective?How to increase the impact of prevention on incident cases?The WMH-ICS initiativeConclusions
Slide3Why is prevention important?
Slide4Why is prevention important?
High prevalence (30.3 million Europeans), 322 million worldwideHigh incidence (almost 50% of prevalence)Huge burden of diseaseHighest burden of disease in 2030 in developed countriesIncrease with 18% between 2005 and 2015 (because of population growth)54 million YLD lost, 80% in LAMI countries
$2.5 – 8.5 trillion in lost output ($2.500.000.000)Treatments can reduce burden of disease with not more than 35% (currently 15%)
Slide5Illnesses with highest disease burden
Illness
% dis. burden
Coronary heart disease
7.6
Anxiety disorders
5.1
Stroke
4.9
Depression / dysthymia
3.9
COPD
3.2
Diabetes mellitus
3.2
Lung cancer3Alcohol dependence2.5Artrosis2.5Dementia2.3
Source: RIVM, 2006
Slide6Top 5 of diseases in The Netherlands
0-14
15-24
25-44
45-64
65-74
75+
1
Innate anomalies
Alcohol
Anxiety
Coron. Heart dis
Coron. Heart dis
Coron. Heart dis
2
Mental handicapsAnxietyDepres-sionAnxietyStrokeStroke3Privat accidents.
Depres-sion
Alcohol
Lung cancerCOPDDementia4Bronchial infections Traffic accidentsSuicideDepres-sionLung cancerCOPD5AsthmaMental handicapsTraffic accidentsDiabetes Diabe-tes Diabetes
Slide7The problem with treatments of depression
Treatments are effective, but effects are limitedOn the one hand: high rates of spontaneous recovery, placebo response
38% reponse in placebo (54% in ADM; Levkovitz et al., 2011)41% in control conditions (54% in psychotherapies; Cuijpers et al., 2014)
Non-treated patients: 23% in 3 months, 53% in 12 months (Whiteford et al., 2012)
The majority of patients would get better anywayOn the other hand: A large group of patients who do not respond to any treatment (~30%)
Cuijpers, Journal of the American Medical Association 2018
Slide8Currently averted YLD
Disorder Current Any mood disorder 15% Major depression 16% Any anxiety disorder 13% Any alcohol rel. dis. 2% Schizophrenia 13% Any disorder 13%Andrews et al., Br J Psychiatry 2004
Slide9Averted YLD (current and with EBMH)
Disorder Current with EBMH Any mood disorder 15% 23% Major depression 16% 23% Any anxiety disorder 13% 20% Any alcohol rel. dis. 2% 5% Schizophrenia 13% 22% Any disorder 13% 20%
Andrews et al., Br J Psychiatry 2004
Slide10Averted YLD (maximum)
Disorder Current EBMH Max Any mood disorder 15% 23% 35% Major depression 16% 23% 34% Any anxiety disorder 13% 20% 49% Any alcohol rel. dis. 2% 5% 34% Schizophrenia 13% 22% 22% Any disorder 13% 20% 40%
Andrews et al., Br J Psychiatry 2004
Slide11ConsequencesCurrently avoided in MDD: 16%, maximum 34%
Currently avoided in anxiety disorders: 13%, maximum 49%Consequences:Better treatmentsDissemination (low/middle-income countries!)Prevention!
Slide12Costs of depression
€132 million per milion adults for MDDOf which 47% is related to the incidenceAbout the same costs in minor depressionAbout twice as much in dysthymiaTotal costs about € 600 million, per million adultsSmit et al. Journal of Mental Health Policy and Economics, 2006
Cuijpers et al. Acta Psychiatrica Scandinavica, 2007
Slide13Costs of depression
2.2% - 4.4% of Gross Domestic Product (GDP) in OECD Member States€610 billion per year across 27 EU Member StatesAbsenteism/presenteism: €270 billionLost output: €240 billionHealth care: €60 billionDisability benefit payments: €40 billion
Slide14Chisholm et al., Lancet Psychiatry 2016
Slide15So why is prevention necessary?
Because of highPrevalenceIncidenceCostsBurden of diseaseLimited possibilities of treatmentBut: Is prevention possible?
Slide16Is prevention effective?
Slide17Overview of the development of the field
During 1970s and 1980s it was considered impossible to prevent mental disordersFirst randomized trial in late 1980s (Ricardo Munoz)More trials started in late 1990sFirst meta-analysis in 2005 (13 trials across all mental disorders; Cuijpers et al., 2005)
Since then: dozens of randomized trials in depression, psychotic disorders, PTSD, eating disordersIn 2014: >30 trials in depression aloneMajor development in 20 years
Slide18Meta-analysis of randomized trials in depression
32 trials (6,214 participants)Universal: 2 studiesSelective: 15 studiesIndicated: 17 studiesDifferent target groupsadolescents/students: 14adults in general: 8pregnant women/young mothes: 9
Other: 1Intervention based onCBT: 15 studiesIPT: 5 studiesPST: 2 studies
Cuijpers et al., Am J Psychiatry 2008; Van Zoonen et al., Int J Epidem 2014
Slide19Type of prevention
Type
N
IRR95% CI
NNTIndicated
17
0.74
0.62~0.89
14
Selective
15
0.81
0.64~1.02
20
Universal
21.010.66~1.53-1000With new improvements (stepped-care; Internet-based) IRR approaches 50%, with NNT=8Growing evidence for cost-effectivenessVan ‘t Veer-Tazelaar et al., Arch Gen Psychiatry 2009; Buntrock et al., JAMA 2016
Slide20Dias et al., JAMA Psychiatry 2019
Slide21Example: Prevention of major depressive disorders through web-based guided self-help
Buntrock et al., Journal of the American Medical Association (JAMA) 2016
Slide22Design and outcomes
406 participants with subthreshold depression (no MDD)Randomized to guided web-based prevention (PST + behavioral activation) or care as usualIncidence of MDD was 27% in the prevention group compared with 41% in the control groupHazard ratio: 0.59 (95% CI: 0.42~0.82) at 12 monthsNNT=6
Slide23Rough example
of how impact of prevention could look like100.000 population5.000 have subthreshold depression
500 10% participate in indicated prevention36 N of cases prevented (
with NNT=14)2000 new cases of MDD
1.7% of new cases are prevented by intervening in 500 people5% if we intervene in 20% and
increase
NNT
to
10 (100 cases)
=> Modest impact
Slide24How to increase the impact of prevention?
Slide25How to increase impact of prevention?
Increase participation among subthresholdIdentify high risk groups
with high incidence ratesFocus
on universal preventionInstitutionalized prevention (Ormel et al., 2019)
Increase effects of interventionsCommunity interventionsGeneral communitiesWorkplace
Schools,
=> Colleges, universities
Slide26World Health Organization World Mental Health International College Student initiative (WMH-ICS)
Slide27International Journal of Methods in Psychiatric Research, 2019
Slide28Three main parts
Epidemiological researchDevelopment and testing of interventions for students (and hopefully including personalizing interventions)Dissemination of interventions at participating universities=> Full community
Slide2925,543 students in 29
universities in
11 countries
Wmh-ICS
Slide30Survey
30
Digital informed consent
Socio-demographic, e.g., age, gender, faculty, etc.
Overall Physical health
Attention and concentration
Emotional problems: depression, GAD, PD, Bipolar disorder, other (e.g., anger)
Alcohol and drug use
Self-harm behaviors
Seeking treatment attitudes
Sexuality
Sleeping patterns
Personality traits
Family
Educational performance
Slide31Journal of Abnormal Psychology, 2018
Slide32rEsults
Surveys started in 2012Started by Prof. Ronny Bruffaerts (Leuven), Ron Kessler (Harvard)Strong increase in number of participating countries and total number of studentsDifferences between countries
>30 papers on many aspects of mental health of college students (suicide, depression, anxiety, help-seeking, treatment rates, role impairment, prevalence/incidence, etc)Second and third part of WMH-ICS not yet well-developedFirst projects have started in Holland, Germany, US
Slide33The dutch ‘branch” of WMH-ICS
33
Four universities:
Vrije Universiteit Amsterdam,
Leiden,
Utrecht
Maastricht
~100,000 university students (1/3 of all Dutch university students)
Slide34Students with psychosocial problems (N=605)
% saying “All the time”% PHQ9 >
5Learn to cope?
Learn to cope (PHQ>5)Procrastination0.23
0.78
0.44
0.50
Self-criticism
0.19
0.88
0.32
0.40
Worrying
0.16
0.930.340.43Perfectionism0.150.720.160.20Low self-esteem0.150.950.330.42
Slide35Development of e-health tools
Any subject that students bring forward (co-creation):DepressionStressProcrastinationSleep
Self-esteemDelivered by trained clinical psychology studentsIn three phases
Development and pilot testing in open study Randomized trial
Dissemination through survey and other channels, across the world
Slide36Two scenarios
Scenario 1
Scenario 2
100,000Population
100,000Population5,000subthresh depr5,000subthresh
depr
500
10%
indicated
prevention
2,500
50%
psychosocial
problems36 Cases prevented250Cases prevented2,000New MDD cases2,000New MDD cases1.7%Prop. prevented12.5%Prop. Prevented0.5 fte750 hours of coach (1.5 hours per case)2.5 fte3750 hours of coach(1.5 hours per case)
Slide37Conclusions
Slide38Conclusions
Public health challenge of depression: high prevalence, disease burden, economic costs, limited effects of treatmentsPrevention can reduce incidence with ~22%, and possibly up to 50%, but impact is smallDevelopment of community interventions may be one method to increase impact
Slide39Thank you for your attention!
Contact: p.cuijpers@vu.nl
Slide40